1. Home
  2. MYGN vs BRBI Comparison

MYGN vs BRBI Comparison

Compare MYGN & BRBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$5.03

Market Cap

444.2M

Sector

Health Care

ML Signal

HOLD

BRBI

BRBI BR Partners S.A. ADSs

N/A

Current Price

$16.32

Market Cap

383.0M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
MYGN
BRBI
Founded
1991
2009
Country
United States
Brazil
Employees
N/A
188
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
444.2M
383.0M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
MYGN
BRBI
Price
$5.03
$16.32
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$7.64
N/A
AVG Volume (30 Days)
1.3M
1.6K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
4.53%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$771,400,000.00
N/A
Revenue This Year
$6.89
N/A
Revenue Next Year
$5.35
$17.24
P/E Ratio
N/A
$11.72
Revenue Growth
2.33
N/A
52 Week Low
$3.76
$12.54
52 Week High
$8.59
$67.01

Technical Indicators

Market Signals
Indicator
MYGN
BRBI
Relative Strength Index (RSI) 58.72 64.70
Support Level $4.23 $13.77
Resistance Level $5.67 $16.46
Average True Range (ATR) 0.27 0.19
MACD 0.06 0.21
Stochastic Oscillator 97.78 97.48

Price Performance

Historical Comparison
MYGN
BRBI

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

About BRBI BRBI BR Partners S.A. ADSs

BRBI BR Partners SA, formerly BR Advisory Partners Participacoes SA, is engaged in investing in other companies, domestic or foreign, as a partner, quota holder, or shareholder, and management of its assets. It has a single reportable segment being investment banking services, which are administered and managed according to the products offered.

Share on Social Networks: